dsm-firmenich has divested its Animal Nutrition & Health business for approximately €2.2 billion, enabling the company to focus on its core nutrition, health, and beauty segments while retaining a 20% equity stake in the divested entity.
Information on the target
dsm-firmenich is a leading global company specializing in nutrition, health, and beauty solutions. The firm has recently announced a strategic roadmap aimed at enhancing its consumer-focused offerings across various segments, including Perfumery & Beauty, Taste, Texture & Health, and Health, Nutrition & Care. The company is set to host an Investor Event in London on March 12, 2026, where it will provide a comprehensive update on its innovation-driven growth profile and financial outlook for the upcoming year.
As part of its ongoing strategy, dsm-firmenich has successfully divested its Animal Nutrition & Health (ANH) business, allowing it to concentrate on core activities that drive organic growth and operational excellence. The divestment, valued at approximately €2.2 billion, includes an earn-out provision and positions the company to leverage its remaining assets for enhanced value creation.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry overview in the target’s specific country
The nutrition and health industry in Europe, particularly in countries like Switzerland where dsm-firmenich is headquartered, is experiencing robust growth driven by increasing consumer awareness of health and wellness. The demand for innovative and sustaina
Similar Deals
Amundi SGR, NRC Capital, and Azimut → Alimac Group
2025
CVC Capital Partners
invested in
Animal Nutrition & Health business of dsm-firmenich
in 2026
in a Buyout deal
Disclosed details
Transaction Size: $2,368M
EBITDA: $350M
Enterprise Value: $2,368M
Equity Value: $474M
Multiples
EV/EBITDA: 6.8x